Redx Pharma half-year loss doubles amid costs of failed Jounce merger

Redx Pharma PLC on Wednesday said its half-year loss nearly doubled, due to lower revenue and higher expenses, but it noted progress in therapeutics trials and said it retains the foundations for... | May 17, 2023

Related Keywords

Redx Pharma ,Lisa Anson ,Emma Curzon ,Concentra Biosciences ,Alliance News Ltd ,Alliance News ,Jounce Therapeutics Inc ,Chief Executive Officer Lisa ,All Rights ,Redx Pharma Plc Stock Exchange ,News ,Information ,Press Release ,Redx ,Dharma ,Lc ,N ,Wednesday ,Aid ,Its ,Boss ,Early ,Ue ,O ,Tower ,Revenue ,End ,Higher ,Nut ,It ,Oted ,Progress ,Herapeutics ,Trials ,Etains ,The ,Oundations Redx Gb00bsnb6s51 ,